Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 12—December 2019
CME ACTIVITY - Synopsis

Seroprevalence and Risk Factors Possibly Associated with Emerging Zoonotic Vaccinia Virus in a Farming Community, Colombia

Ashley StyczynskiComments to Author , Jillybeth Burgado, Diana Walteros, José Usme-Ciro, Katherine Laiton, Alejandra Pinilla Farias, Yoshinori Nakazawa, Christina Chapman, Whitni Davidson, Matthew Mauldin, Clint Morgan, Juan Martínez-Cerón, Edilson Patiña, Leidy Laura López Sepúlveda, Claudia Patricia Torres, Anyely Eliana Cruz Suarez, Gina Paez Olaya, Carlos Elkin Riveros, Diana Yaneth Cepeda, Leydi Acosta Lopez, Daniela Gomez Espinosa, Faiber Antonio Gutierrez Lozada, Yu Li, P.S. Satheshkumar, Mary Reynolds, Martha Gracia-Romero, and Brett Petersen
Author affiliations: Centers for Disease Control and Prevention, Atlanta, GA, USA (A. Styczynski, J. Burgado, Y. Nakazawa, C. Chapman, W. Davidson, M. Mauldin, C. Morgan, Y. Li, P.S. Satheshkumar, M. Reynolds, B. Petersen); Instituto Nacional de Salud, Bogotá, Colombia (D. Walteros, J. Usme-Ciro, K. Laiton, A.P. Farias, M. Gracia-Romero); Universidad Cooperativa de Colombia, Santa Marta, Colombia (J. Usme-Ciro); Universidad de Antioquia, Medellín, Colombia (J. Martínez-Cerón, E. Patiña, L.L. López Sepúlveda); Secretaria de Salud de Cundinamarca, Bogotá (C.P. Torres, A.E. Cruz Suarez, G.P. Olaya, C.E. Riveros); Hospital Nuestra Señora del Pilar de Medina, Medina, Colombia (D.Y. Cepeda); Vigilancia en Salud Publica, Bogotá (L.A. Lopez); Universidad Javeriana, Bogotá (D.G. Espinosa); Secretaria de Salud de Caquetá, Florencia, Columbia (F.A. Gutierrez Lozada)

Main Article

Table 2

Characteristics of 18 OPXV-seropositive persons with history of vaccinia-like lesions among farmworkers and household members from 56 farms in Cundinamarca Department, Colombia, August–September 2016*

Characteristic Value
Age <44 y
 12 (66.6)
Location of lesion(s)†
Hand 17 (94.4)
Eyes 3 (16.7)
Arm 1 (5.6)
Face or neck 1 (5.6)
Leg
 0
Median no. lesions (range) 1.5 (1–6)
Prior injury at site of lesion 5 (27.8)
Residual scar 13 (72.2)
Time off work because of lesion(s), d 10 (55.6)
Median time off work, d (range) 10 (3–15)
Evaluated by physician 11 (61.1)
Hospitalized
 2 (11.1)
Lesion symptoms
Localized pain 18 (100.0)
Pruritus 17 (94.4)
Swelling 15 (83.3)
Warmth 14 (77.8)
Discharge 12 (66.7)
Lymphangitis
 11 (61.1)
Constitutional symptoms
Generalized pain 10 (55.6)
Headache 10 (55.6)
Fever after lesion 10 (55.6)
Fever before lesion 4 (22.2)
Chills or rigors 4 (22.2)
Lymphadenopathy 3 (16.7)
Arthralgias 1 (5.6)
Myalgias 1 (5.6)

*Values are no. (%) persons except as indicated. OPXV, orthopoxvirus.
†Number of lesion locations is >18 because some persons had >1 lesion.

Main Article

Page created: November 14, 2019
Page updated: November 14, 2019
Page reviewed: November 14, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external